ArticleFrontiers in medicine2026
Phenotype-informed management of preoperative asymptomatic isolated muscular calf vein thrombosis in patients undergoing primary total knee arthroplasty under standardized thromboprophylaxis: a retrospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Perioperative coagulation shifts after degenerative lumbar surgery and exploratory lower-limb thrombosis signals.Frontiers in surgery · 2026Article
- Meta-analysis of the effectiveness of ankle pump exercise combined with anticoagulant therapy for the prevention of post-operative lower extremity deep vein thrombosis.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited evidence exists regarding the management of preoperative screen-detected (by duplex ultrasonography) asymptomatic isolated muscular calf vein thrombosis (MCVT) before total knee arthroplasty (TKA). We evaluated the outcomes when TKA was performed as scheduled, without preoperative therapeutic-dose anticoagulation, using a standardized thromboprophylaxis and enhanced recovery after surgery (ERAS) pathway. Methods: Consecutive adults undergoing primary unilateral TKA from 2019 to 2023 received bilateral duplex ultrasonography within 5 days before surgery. The MCVT group comprised patients with asymptomatic isolated gastrocnemius or soleal vein thrombosis, with no involvement of axial deep calf veins or the popliteal vein; the control group had no thrombosis. All patients received a standardized pharmacological prophylaxis regimen (enoxaparin in-hospital followed by rivaroxaban after discharge, total duration 14 days), along with mechanical prophylaxis and early mobilization. The primary outcome was symptomatic venous thromboembolism (VTE) within 90 days. Secondary outcomes included duplex ultrasonography findings on postoperative day 5, bleeding events [defined by International Society on Thrombosis and Hemostasis (ISTH) criteria], Knee Society Score (KSS) at 90 days, and length of stay. Results: Among 454 patients included, 44 (9.7%) had an isolated preoperative MCVT. No patients in either group developed symptomatic VTE or pulmonary embolism (0/44 vs. 0/410, 95% CI 0.0%-8.0% and 0.0%-0.9%). Routine duplex ultrasonography on postoperative day 5 showed no thrombus progression or new deep vein thrombosis (DVT) in either group. No ISTH-defined major bleeding or clinically relevant non-major bleeding (CRNMB) occurred. KSS outcomes and length of stay were similar between groups (all Conclusion: Under a protocolized ERAS pathway with combined mechanical prophylaxis and standard chemoprophylaxis, we observed no clinically evident thrombotic or bleeding events within 90 days in patients with asymptomatic isolated preoperative MCVT who proceeded to TKA without delay or preoperative therapeutic-dose anticoagulation. These findings are descriptive and hypothesis-generating and cannot exclude rare but clinically important differences; prospective multicenter studies are needed to quantify rare events and clarify generalizability across thrombus profiles and prophylaxis regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.